Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build Kenya flag

Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

: Kenya Radiotherapy Intent Code System

Active as of 2026-06-04

Raw json | Download

{
  "resourceType" : "CodeSystem",
  "id" : "rt-intent-cs",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem rt-intent-cs</b></p><a name=\"rt-intent-cs\"> </a><a name=\"hcrt-intent-cs\"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/rt-intent-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">CURATIVE<a name=\"rt-intent-cs-CURATIVE\"> </a></td><td>Curative</td><td>Radical RT aimed at cure or complete local control.</td></tr><tr><td style=\"white-space:nowrap\">PALLIATIVE<a name=\"rt-intent-cs-PALLIATIVE\"> </a></td><td>Palliative</td><td>RT to relieve symptoms (pain, bleeding, obstruction).</td></tr><tr><td style=\"white-space:nowrap\">ADJUVANT<a name=\"rt-intent-cs-ADJUVANT\"> </a></td><td>Adjuvant</td><td>RT given after surgery to reduce local recurrence risk.</td></tr><tr><td style=\"white-space:nowrap\">NEO-ADJUVANT<a name=\"rt-intent-cs-NEO-ADJUVANT\"> </a></td><td>Neo-adjuvant</td><td>Pre-operative RT to downstage the tumour.</td></tr><tr><td style=\"white-space:nowrap\">PROPHYLACTIC<a name=\"rt-intent-cs-PROPHYLACTIC\"> </a></td><td>Prophylactic</td><td>RT to prevent disease at a site of potential spread.</td></tr><tr><td style=\"white-space:nowrap\">SALVAGE<a name=\"rt-intent-cs-SALVAGE\"> </a></td><td>Salvage</td><td>RT for recurrent disease after prior local treatment.</td></tr><tr><td style=\"white-space:nowrap\">STEREOTACTIC<a name=\"rt-intent-cs-STEREOTACTIC\"> </a></td><td>Stereotactic (SRS/SBRT)</td><td>High-precision single or few-fraction RT.</td></tr><tr><td style=\"white-space:nowrap\">RADIOSURGERY<a name=\"rt-intent-cs-RADIOSURGERY\"> </a></td><td>Radiosurgery</td><td>Single-fraction stereotactic treatment.</td></tr><tr><td style=\"white-space:nowrap\">CONCURRENT-CRT<a name=\"rt-intent-cs-CONCURRENT-CRT\"> </a></td><td>Concurrent Chemo-RT</td><td>RT given concurrently with chemotherapy.</td></tr></table></div>"
  },
  "url" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/rt-intent-cs",
  "version" : "0.1.0",
  "name" : "RTIntentCS",
  "title" : "Kenya Radiotherapy Intent Code System",
  "status" : "active",
  "experimental" : false,
  "date" : "2026-06-04T14:49:30+00:00",
  "publisher" : "Digital Health Agency (DHA), Kenya",
  "contact" : [
    {
      "name" : "Digital Health Agency (DHA), Kenya",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://dha.go.ke"
        },
        {
          "system" : "email",
          "value" : "info@dha.go.ke"
        }
      ]
    },
    {
      "name" : "Digital Health Agency Kenya – FHIR Team",
      "telecom" : [
        {
          "system" : "email",
          "value" : "info@dha.go.ke",
          "use" : "work"
        },
        {
          "system" : "url",
          "value" : "https://dha.go.ke",
          "use" : "work"
        }
      ]
    }
  ],
  "description" : "Codes for the clinical intent of a radiotherapy treatment course.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "KE",
          "display" : "Kenya"
        }
      ]
    }
  ],
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 9,
  "concept" : [
    {
      "code" : "CURATIVE",
      "display" : "Curative",
      "definition" : "Radical RT aimed at cure or complete local control."
    },
    {
      "code" : "PALLIATIVE",
      "display" : "Palliative",
      "definition" : "RT to relieve symptoms (pain, bleeding, obstruction)."
    },
    {
      "code" : "ADJUVANT",
      "display" : "Adjuvant",
      "definition" : "RT given after surgery to reduce local recurrence risk."
    },
    {
      "code" : "NEO-ADJUVANT",
      "display" : "Neo-adjuvant",
      "definition" : "Pre-operative RT to downstage the tumour."
    },
    {
      "code" : "PROPHYLACTIC",
      "display" : "Prophylactic",
      "definition" : "RT to prevent disease at a site of potential spread."
    },
    {
      "code" : "SALVAGE",
      "display" : "Salvage",
      "definition" : "RT for recurrent disease after prior local treatment."
    },
    {
      "code" : "STEREOTACTIC",
      "display" : "Stereotactic (SRS/SBRT)",
      "definition" : "High-precision single or few-fraction RT."
    },
    {
      "code" : "RADIOSURGERY",
      "display" : "Radiosurgery",
      "definition" : "Single-fraction stereotactic treatment."
    },
    {
      "code" : "CONCURRENT-CRT",
      "display" : "Concurrent Chemo-RT",
      "definition" : "RT given concurrently with chemotherapy."
    }
  ]
}